Pádraig O'Sullivan (Cork North Central, Fianna Fail) | Oireachtas source

I have previously raised the issue of drug reimbursement in this country with the Tánaiste and the Taoiseach and last week, the Swedish Institute for Health Economics published a report on cancer outcomes in Ireland. It found that while much progress was made, we are still among the worst in the EU for ovarian and breast cancer outcomes. The report specifically cited that our drug reimbursement system is not fit for purpose and that it costs the equivalent of 2,600 life years per annum due to the cumbersome nature of the reimbursement process. Can we, please, prioritise the publication of the Mazars report, which looks into reimbursement, and update the rare disease plan, which expired since 2018? When the Tánaiste assumes the office of Taoiseach in the new year, I hope he makes this a priority.

See this speech in context